化合物TPX0005 T4071
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mg | 1802220-02-5 | ¥297.00 | 询底价 |
2 mg | 1802220-02-5 | ¥423.00 | 询底价 |
5 mg | 1802220-02-5 | ¥663.00 | 询底价 |
50 mg | 1802220-02-5 | ¥2,880.00 | 询底价 |
1 mL | 1802220-02-5 | ¥713.00 | 询底价 |
100 mg | 1802220-02-5 | ¥4,270.00 | 询底价 |
25 mg | 1802220-02-5 | ¥1,970.00 | 询底价 |
10 mg | 1802220-02-5 | ¥997.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Repotrectinib
描述: Repotrectinib (TPX-0005) 是ROS1(IC50=0.07 nM) 和TRK(对 TRKA/B/C 的IC50=0.83/0.05/0.1 nM) 抑制剂,能够抑制 WTALK(IC50=1.01 nM)。它具有抗癌作用。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 60 mg/mL (168.84 mM)
关键字: ALK tyrosine kinase receptor | ROS Kinase | Trk Receptor | inhibit | Cluster of differentiation 246 | CD246 | Anaplastic lymphoma kinase (ALK) | Tropomyosin related kinase receptor | Anaplastic lymphoma kinase | Inhibitor | Repotrectinib
相关产品: Crizotinib hydrochloride | ROS kinases-IN-2 | APG-2449 | Anti-inflammatory agent 64 | Crizotinib | Merestinib | Salvigenin | Lorlatinib | Uniconazole | Taletrectinib free base
相关库: Drug Repurposing Compound Library | FDA-Approved Kinase Inhibitor Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Inhibitor Library | Kinase Inhibitor Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library | Tyrosine Kinase Inhibitor Library | Anti-Cancer Active Compound Library
化合物TPX0005 T4071信息由TargetMol中国为您提供,如您想了解更多关于化合物TPX0005 T4071报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途